Overview
- Boston Scientific disclosed a cybersecurity incident that has restricted access to some information systems and business applications used to process customer orders and ship products.
- The company has launched a formal investigation and engaged third-party cybersecurity firms to assess the threat and contain the incident.
- Boston Scientific warned operational limitations will continue and has not yet determined the full scope of the attack or whether it will have a material business impact.
- Investors reacted quickly to the disclosure, with the stock falling about 4% in early trading after the company publicized the disruption.
- Supply chains for hospitals and other customers could face delays while systems remain limited, and the incident adds to rising regulatory and market scrutiny of cyberattacks on medical device companies.